Publicación: Tendencias en el uso y presentación de los reportes de sostenibilidad en compañías farmacéuticas a nivel mundial: “divulgación y transparencia informativa para los diferentes Stakeholders”
Portada
Citas bibliográficas
Código QR
Director
Autor corporativo
Recolector de datos
Otros/Desconocido
Director audiovisual
Editor/Compilador
Editores
Tipo de Material
Fecha
Cita bibliográfica
Título de serie/ reporte/ volumen/ colección
Es Parte de
Resumen
This project sought to analyze the information contained in the sustainability reports regarding the characteristic of transparency in its disclosure and its importance for stakeholders and / or Stakeholders. A mixed methodology is used, and the Multiple Study Companies are determined, which are Sanofi, Merck & Co and Merck, then a search is carried out in these databases, for the development of the investigation, analyzing the sustainability reports of the last three years, the quality of the information that these organizations handled to account for the level of transparency that they handled in the disclosed information. In this scenario, the behavior and trend that these companies manage for the disclosure of information during the last three years is evidenced, generating as results of the investigation, factors such as: For Merck Pharmaceutical, it only presented 176 indicators, with a level of compliance 65%. For Merck & Co. Inc. Pharmaceuticals, I only presented 128 indicators, with a compliance level of only 48%. And for Sanofi Pharmaceuticals, I only presented 134 indicators, with a compliance level of 49%, identifying in the course of this work their level of transparency in the different reports analyzed.